Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)

Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine

“…The results of our study are consistent with those published by Antrobus et al [ 20 ], where co-administration of a seasonal IIV (TIV) and a modified vaccinia virus Ankara-NP + matrix protein M1 (MVA-NP+M1) elicited potent HA humoral and NP+M1 CMI responses. They found that the co-administration group had higher GMRs against the H3N2 vaccine strain than the IIV + placebo group.…”

Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine

“…The results of our study are consistent with those published by Antrobus et al [ 20 ], where co-administration of a seasonal IIV (TIV) and a modified vaccinia virus Ankara-NP + matrix protein M1 (MVA-NP+M1) elicited potent HA humoral and NP+M1 CMI responses. They found that the co-administration group had higher GMRs against the H3N2 vaccine strain than the IIV + placebo group.…”

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China

“…The most frequently reported AEFI following DTP-IPV/Hib was categorized as the minor vaccine product-related reaction or non-serious. Our findings was consistent with the results obtained from a meta-analysis, 25 in which the minor reactions such as pain and redness were more prevalent among the children received the combined vaccines. Our previous reports also revealed that the majority of the AEFI were non-serious events.…”

A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine

“…10 A recent Cochrane review comparing combined DTP-HepBHib vaccine with separately administered DTP-HepB and Hib vaccines observed that minor adverse events such as pain and redness were more common in children given the combined vaccine; however overall, the direction was in favor of the DTPw-HBHib vaccine rather than the DTPa-HB-Hib vaccine when compared to the separate vaccines. 11 Our results are also in line with those reported with other DTwP-HepB-Hib vaccine studies. These include a study in Turkey on Tritanrix-HBCHib, 12 a study in India on EasyFive 13 and one more study in India 14 on Shan5 TM , EasyFive TM and Tritanrix-HB TM C Hiberix TM .…”

Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine

“…The results of our study are consistent with those published by Antrobus et al [ 20 ], where co-administration of a seasonal IIV (TIV) and a modified vaccinia virus Ankara-NP + matrix protein M1 (MVA-NP+M1) elicited potent HA humoral and NP+M1 CMI responses. They found that the co-administration group had higher GMRs against the H3N2 vaccine strain than the IIV + placebo group.…”

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China

“…The most frequently reported AEFI following DTP-IPV/Hib was categorized as the minor vaccine product-related reaction or non-serious. Our findings was consistent with the results obtained from a meta-analysis, 25 in which the minor reactions such as pain and redness were more prevalent among the children received the combined vaccines. Our previous reports also revealed that the majority of the AEFI were non-serious events.…”

A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine

“…10 A recent Cochrane review comparing combined DTP-HepBHib vaccine with separately administered DTP-HepB and Hib vaccines observed that minor adverse events such as pain and redness were more common in children given the combined vaccine; however overall, the direction was in favor of the DTPw-HBHib vaccine rather than the DTPa-HB-Hib vaccine when compared to the separate vaccines. 11 Our results are also in line with those reported with other DTwP-HepB-Hib vaccine studies. These include a study in Turkey on Tritanrix-HBCHib, 12 a study in India on EasyFive 13 and one more study in India 14 on Shan5 TM , EasyFive TM and Tritanrix-HB TM C Hiberix TM .…”

Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine

“…The results of our study are consistent with those published by Antrobus et al [ 20 ], where co-administration of a seasonal IIV (TIV) and a modified vaccinia virus Ankara-NP + matrix protein M1 (MVA-NP+M1) elicited potent HA humoral and NP+M1 CMI responses. They found that the co-administration group had higher GMRs against the H3N2 vaccine strain than the IIV + placebo group.…”

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China

“…The most frequently reported AEFI following DTP-IPV/Hib was categorized as the minor vaccine product-related reaction or non-serious. Our findings was consistent with the results obtained from a meta-analysis, 25 in which the minor reactions such as pain and redness were more prevalent among the children received the combined vaccines. Our previous reports also revealed that the majority of the AEFI were non-serious events.…”

A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine

“…10 A recent Cochrane review comparing combined DTP-HepBHib vaccine with separately administered DTP-HepB and Hib vaccines observed that minor adverse events such as pain and redness were more common in children given the combined vaccine; however overall, the direction was in favor of the DTPw-HBHib vaccine rather than the DTPa-HB-Hib vaccine when compared to the separate vaccines. 11 Our results are also in line with those reported with other DTwP-HepB-Hib vaccine studies. These include a study in Turkey on Tritanrix-HBCHib, 12 a study in India on EasyFive 13 and one more study in India 14 on Shan5 TM , EasyFive TM and Tritanrix-HB TM C Hiberix TM .…”